| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Relay Therapeutics, Inc.'s insiders have reduced their positions by a net 8,660 shares worth roughly $162K.
RLAY sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.45M | $28.67M | - | |
| Pres | 409.9K | $8.10M | - | |
| Other | 276.6K | $5.47M | - | |
| CFO | 213.9K | $4.23M | - | |
| Dir | 207.9K | $4.11M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2022 | Patel Sanjiv73 | President And CEO | Sale+OE | 42,000 | $21.04 | $883,680.00 | -5.2% | -18.7% | -62.2% | |
| Oct 3, 2022 | Bergstrom Donald A74 | President, R&D | Sale+OE | 8,000 | $22.43 | $179,440.00 | -8.3% | -32.6% | -60.8% | |
| Sep 27, 2022 | Porter Andy77 | Chief Administrative Officer | Sell | 259 | $22.73 | $5,887.07 | -0.6% | -38.1% | -64.5% | |
| Sep 27, 2022 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 443 | $22.73 | $10,069.39 | -0.8% | -38.1% | -64.5% | |
| Sep 27, 2022 | Bergstrom Donald A74 | President, R&D | Sell | 976 | $22.73 | $22,184.48 | -1.1% | -38.1% | -64.5% | |
| Sep 27, 2022 | Adams Brian71 | Chief Legal Officer | Sell | 294 | $22.73 | $6,682.62 | -0.5% | -38.1% | -64.5% | |
| Sep 15, 2022 | Patel Sanjiv73 | President And CEO | Sale+OE | 42,000 | $24.24 | $1,018,080.00 | -5.2% | -30.2% | -62.6% | |
| Sep 8, 2022 | Murcko Mark | Director | Sell | 25,000 | $29.95 | $748,750.00 | -2.4% | -44.4% | -69.0% | |
| Sep 8, 2022 | Catinazzo Thomas69 | Chief Financial Officer | Sale+OE | 26,257 | $30.00 | $787,710.00 | -33.5% | -44.4% | -69.0% | |
| Sep 8, 2022 | Bergstrom Donald A74 | President, R&D | Sale+OE | 25,000 | $30.00 | $750,000.00 | -21.8% | -44.4% | -69.0% |